Yayi Yuan
Nan Wang1
Kang Ning- 1Key Laboratory of Molecular Biophysics of the Ministry of Education, Hubei Key Laboratory of Bioinformatics and Molecular-imaging, Center of AI Biology, Department of Bioinformatics and Systems Biology, College of Life Science and Technology, Huazhong University of Science and Technology, Hubei, China
- 2China National Nuclear Corporation (CNNC) Key Laboratory for Radiation Protection Technology, Shanxi Key Laboratory for Radiation Safety and Protection, Department of Radiology and Environmental Medicine, China Institute for Radiation Protection, Taiyuan, China
Radiation therapy is widely used for the treatment of brain tumors and metastases from extracranial malignancies; however, it may also cause damage to normal brain tissue, potentially resulting in radiation-induced brain injury (RBI). Emerging evidence highlights the microbiota–gut–brain axis (MGBA) as a critical mediator of bidirectional communication between the gut microbiota and the brain, playing an important role in central nervous system (CNS) homeostasis and pathology. This review aims to summarize current evidence regarding the potential involvement of the MGBA in the pathogenic mechanisms of RBI, with particular emphasis on bidirectional interactions along this axis. We focus on underlying mechanisms, including neuroimmune and inflammatory responses, signal transduction, DNA damage, and oxidative stress. By integrating these perspectives, this review seeks to provide a novel conceptual framework for understanding RBI and to identify potential directions for future MGBA-targeted interventions.
1 Introduction
Radiation therapy is a cornerstone in the treatment of malignant tumors and is widely applied in the management of primary brain tumors and metastases from extracranial malignancies (1). In the United States alone, more than 200,000 patients undergo whole-brain irradiation each year (2). Although cranial irradiation is effective for tumor control, it inevitably exposes adjacent normal brain tissue to radiation, which may result in radiation-induced brain injury (RBI). RBI is primarily characterized by cerebral edema, demyelination, cognitive impairment, memory deficits, and other functional disturbances (3, 4). Notably, 30%–50% of survivors following whole-brain radiotherapy develop clinically significant cognitive decline, which profoundly compromises central nervous system (CNS) function and severely affects long-term quality of life (5–8).
The pathogenesis of these effects involves a dynamic interplay of multiple biological processes. The prevailing view holds that RBI is driven by interactions among vascular injury, neuroinflammation, cellular dysfunction, and molecular disturbances (4, 7, 9, 10). A central mechanism involves the concurrent effects of radiation on brain microvascular endothelial cells and microglia, leading to disruption of the blood–brain barrier (BBB) and early-stage neuroinflammation, which together form a vicious cycle. The resulting chronic inflammatory milieu promotes neuronal apoptosis and synaptic dysfunction and triggers toxic responses in astrocytes and oligodendrocytes, ultimately leading to demyelination. Activation of signaling pathways associated with oxidative stress and nuclear factor kappa B (NF-κB), together with the engagement of emerging cell death pathways such as ferroptosis, collectively forms a complex injury network. This network ultimately results in cognitive impairment and other long-term or irreversible neurological deficits.
This complex injury network constitutes the pathological basis of RBI. In recent years, in addition to the mechanisms described above, increasing attention has been directed toward the role of the microbiota–gut–brain axis (MGBA). The gastrointestinal tract harbors a vast community of commensal microorganisms, currently estimated to be approximately equal in number to human cells in the body (11). A bidirectional regulatory relationship exists between this microbial community and the brain. On the one hand, the brain exerts “top-down” regulation over gastrointestinal motility, sensation, secretory function, and local immune status via the vagus nerve and neuroendocrine pathways (12–15). On the other hand, the gut microbiota influences brain function, emotion, cognition, and BBB integrity in a “bottom-up” manner through neural, immune, endocrine, and metabolic pathways, mediated by microbial metabolites, neuroactive substances, and immunomodulatory signals (16–18).
Importantly, ionizing radiation, while inducing brain injury, can also indirectly disrupt the intestinal microenvironment, leading to gut microbial dysbiosis (19). The disturbed gut microbiota may subsequently act as a persistent source of pathological signals, exacerbating central neuroinflammation, impairing neural repair, and aggravating cognitive dysfunction through ascending MGBA pathways (16, 20). Research by Cui et al. has provided compelling evidence that the gut microbiota plays a critical role in the initiation and progression of radiation-induced injury. Their study demonstrated that transplantation of fecal microbiota from healthy donor mice into irradiated mice significantly improved survival and promoted structural and functional repair of the damaged intestinal epithelium. In contrast, transplantation of feces from mice with radiation proctitis into germ-free mice markedly increased susceptibility to intestinal radiation injury (21).
Nevertheless, the specific mechanisms underlying bidirectional MGBA interactions in the context of RBI remain incompletely understood. This review aims to explore the potential mechanisms linking the gut microbiota and RBI via the MGBA, focusing on immunity and inflammation, signal transduction, DNA damage, and oxidative stress. A clearer understanding of these mechanisms may provide a foundation for the development of novel therapeutic strategies for RBI.
2 Immunity and inflammation
The immune system maintains a symbiotic relationship with the gut microbiota to preserve host homeostasis (22, 23). These microbial communities participate in host metabolic processes, promote the maturation of intestinal immune cells, and contribute to the maintenance of internal physiological balance (24, 25).
2.1 Impact of RBI on the intestinal tract and microbiota
RBI may exert a significant “top-down” influence on distal intestinal homeostasis through the MGBA, primarily manifested as direct damage to intestinal structure and barrier function, as well as disruption of the intestinal microenvironment and microbial community stability.
First, RBI induces intestinal structural injury and barrier dysfunction (26–29). Experimental studies have shown that mice exposed to a single dose of 15 Gy whole-brain irradiation develop pathological alterations, including damaged intestinal epithelial cells, reduced villus number and length, and disrupted intercellular junctions, resulting in severe impairment of intestinal barrier integrity (26, 28). This breach of the physical barrier predisposes the intestine to subsequent microbial dysbiosis and immune activation. Notably, supplementation with Lactobacillus reuteri significantly alleviated pathological intestinal damage in irradiated mice and reduced in vivo levels of key pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), providing further evidence for the critical involvement of intestinal injury and inflammatory responses in RBI (30, 31).
Second, RBI may induce alterations in the intestinal microenvironment through neuroendocrine and inflammatory mediators. Following cranial irradiation, activated glial cells and damaged tissues release a range of inflammatory signals that act on the intestine via the circulatory system or neural pathways (20, 27, 32, 33). Specifically: (1) Pro-inflammatory cytokine–driven disruption. Studies have demonstrated that blockade of TNF-α signaling with anti–TNF-α antibodies significantly alters gut microbiota composition and markedly attenuates intestinal inflammation, indicating that TNF-α exacerbates intestinal inflammatory responses and modulates microbial composition (34). (2) Impaired anti-inflammatory and repair functions. Under physiological conditions, the gut microbiota induces a mild inflammatory response that stimulates regulatory T cells to produce interleukin-10 (IL-10) (35). IL-10 subsequently exerts anti-inflammatory effects, protecting the host from excessive inflammation while supporting the survival of the gut microbiota (13, 35). IL-10 deficiency leads to severe microbial dysbiosis; studies have shown that IL-10–deficient mice exhibit expanded populations of Firmicutes and Bacteroidetes, with Escherichia coli increasing by approximately two orders of magnitude, suggesting that the role of IL-10 in maintaining microbial homeostasis after RBI may be compromised (36). (3) Dysregulation of key immune modulation. Transforming growth factor–β (TGF-β) plays a critical role in maintaining gut microbiota stability. Loss of TGF-β signaling results in an abnormal increase in Enterobacteriaceae, particularly E. coli, within dendritic cells of the intestinal lamina propria (27, 33, 37, 38).
In summary, RBI initiates a “descending” pathway along the MGBA. Injury to neurons or glial cells alters the cerebral microenvironment, leading to the production of inflammatory mediators that indirectly disrupt intestinal function and gut microbiota homeostasis (20, 33) (Figure 1A). Inflammatory factors serve as key molecular mediators in this process.
Figure 1. Role of the gut–brain axis in immune inflammation in radiation brain injury. (A) Gut microbiota and metabolites (e.g., SCFAs) maintain microglial homeostasis. Post-RBI gut dysbiosis and BBB disruption promote peripheral immune cell infiltration and inflammatory mediator access, triggering aberrant M1 polarization of microglia. This leads to neurotoxic cytokine release (IL-1β, IL-6, TNF-α), suppressed neurogenesis, and cognitive dysfunction. (B) SCFAs (butyrate/propionate) regulate microglial maturation/function via HDAC1 inhibition and exert anti-inflammatory effects; RBI-induced SCFA decline exacerbates neuroinflammation. Primary bile acids activate S1PR2 to promote neuroinflammation. Tryptophan derivatives activate microglial AHR, promoting astrocytic TGF-α and inhibiting VEGF-β to alleviate CNS inflammation. (C) Ionizing radiation directly damages BBB (endothelial injury, claudin-5 downregulation, HMGB1 release), increasing permeability. RBI-associated gut dysbiosis elevates circulating gut-derived factors (e.g., LPS). These factors cross the impaired BBB into the CNS, forming a toxic inflammatory milieu and exacerbating the neuroinflammation vicious cycle. (D) Gut microbiota promotes the maturation of meningeal NK cells to produce anti-inflammatory IFN-γ. These gut-licensed IFN-γ+ NK cells migrate into the brain parenchyma, inducing astrocytes to polarize into the anti-inflammatory LAMP1+TRAIL+ phenotype and thereby suppressing CNS inflammation. Created in BioRender. Jiejie, W. (2026) https://BioRender.com/necagsv.
2.2 Influence of the gut microbiota on RBI
The gut is the largest immune organ in the human body, harboring approximately 70%–80% of total immune cells. The gut microbiota and its metabolites can influence the CNS through multiple “bottom-up” pathways, including direct interactions with intestinal immune cells or neural fibers, as well as indirect modulation of brain function through the secretion of microbial metabolites (20, 33, 39, 40). Intestinal dysbiosis induced by RBI can, in turn, exacerbate neuroinflammation and brain injury through several mechanisms.
2.2.1 Aberrant activation of microglia
Microglia, the primary innate immune cells of the CNS, have their maturation, morphology, and functional homeostasis regulated by the gut microbiota and its metabolites (41). Among these, microbial-derived short-chain fatty acids (SCFAs), which reach the brain via the circulatory system, are essential for normal microglial development and functional maintenance (41, 42). Studies have shown that microglia in germ-free or antibiotic-treated mice exhibit developmental immaturity and functional impairment, underscoring the critical role of the gut microbiota in shaping central immune cell function (20, 33, 43, 44)(Figure 1A).
A stable gut microbial community is fundamental to maintaining physiological microglial function, and its disruption can exacerbate neural injury (45). However, gut dysbiosis following RBI perturbs this homeostasis. Microbial imbalance results in reduced levels of beneficial metabolites, such as SCFAs, and conveys persistent injury signals to the brain through enhanced intestinal and systemic low-grade inflammation. For example, Citrobacter-induced intestinal infection has been shown to aggravate microglia-mediated neuroinflammation, leading to expansion of brain lesions (45). In addition, intestinal dysbiosis intensifies gut inflammation, facilitating the migration of peripheral immune cells into the brain, where they interact with resident microglia and other neural cells to collectively amplify the cerebral immune response (20, 46)(Figure 1A).
Following RBI, disruption of the BBB permits peripheral inflammatory mediators to infiltrate the brain and activate microglia (4, 6, 33, 47, 48). Aberrantly activated microglia predominantly polarize toward the pro-inflammatory M1 phenotype and release large quantities of neurotoxic cytokines, including IL-1β, IL-6, and TNF-α (4, 49, 50). These cytokines inhibit the proliferation and differentiation of neuronal precursor cells and impair neurorepair processes. Such polarization represents not only a marker of inflammation but also an effector mechanism that drives neuronal injury, suppresses hippocampal neurogenesis, and ultimately leads to cognitive dysfunction (51) (Figure 1A).
Animal studies have demonstrated that rats exposed to a cumulative dose of 40 Gy (administered as 5 Gy fractions twice weekly via whole-brain ¹³7Cs γ-irradiation for four consecutive weeks) exhibit persistent microglial activation and sustained TNF-α release, accompanied by hippocampal dysfunction, for up to six months (52). These findings indicate that aberrant microglial activation can persist long after radiation exposure and is closely associated with long-term cognitive impairment, providing an important basis for chronic neurological deficits (Figure 1A).
Depletion or inhibition of hyperactivated microglia has been shown to alleviate post-radiation neuroinflammation and cognitive impairment (32). In addition, remodeling of the central immune milieu through transplantation of brain macrophages with protective properties can exert neuroprotective effects. In C57BL/6J mice subjected to whole-brain irradiation (three fractions of 3.3 Gy of ¹³7Cs γ-rays delivered at a dose rate of 2.58 Gy/min), replacement of resident microglia with engrafted brain macrophages protected against long-term cognitive deficits induced by whole-brain radiotherapy (40). Furthermore, certain probiotics, through modulation of the gut microbiota, inhibition of microglial activation, and reduction of pro-inflammatory cytokine levels, represent a potential upstream intervention strategy for RBI via the MGBA (53).
2.2.2 Changes in microbial metabolites
The gut microbiota produces a variety of neuroactive metabolites that function as critical signaling molecules mediating ascending influences along the MGBA (Figure 1B).
SCFAs: Butyrate, propionate, and related SCFAs play indispensable roles in regulating microglial maturation and function (54). Studies using germ-free mouse models have confirmed that SCFA deficiency leads to immature microglial development, aberrant morphology, and functional impairment, whereas exogenous SCFA supplementation can reverse these abnormalities (48, 55). Propionate and butyrate may inhibit histone deacetylase 1 (HDAC1) activity, thereby increasing histone H3 acetylation, which contributes to the normalization of microglial morphology and reduction in the expression of inflammatory mediators such as IL-6, IFN-γ, and CCL2 (56). SCFAs also exert direct anti-inflammatory effects. For example, butyrate downregulates the expression of pro-inflammatory genes within the intestinal immune system, and a reduction in butyrate-producing bacteria is closely associated with a pro-inflammatory state (57, 58). It is therefore hypothesized that a decline in SCFA levels following RBI may weaken endogenous anti-inflammatory capacity, thereby exacerbating neuroinflammation (Figure 1B).
Bile Acids: The gut microbiota can convert primary bile acids into secondary bile acids, which constitute an important class of signaling molecules. These bile acids can modulate neuroimmune responses through the activation of specific receptors. For example, conjugated bile acids (e.g., taurocholic acid) can activate sphingosine-1-phosphate receptor 2 (S1PR2), thereby promoting neuroinflammation under pathological conditions (59). In contrast, secondary bile acids (e.g., deoxycholic acid) can activate G protein-coupled bile acid receptor 5 (TGR5), which inhibits microglial activation and consequently exerts anti-inflammatory effects (60, 61). RBI-induced dysbiosis may disrupt the bile acid metabolic profile, thereby disturbing the balance between neuroprotective and neurotoxic effects mediated by different receptors and ultimately influencing disease progression (Figure 1B).
Tryptophan Derivatives: Indole compounds produced through microbial metabolism act as endogenous ligands for the aryl hydrocarbon receptor (AHR). Activation of the AHR signaling pathway in microglia enables communication with neighboring astrocytes. These signals can promote the production of protective transforming growth factor-alpha (TGF-α) while simultaneously inhibiting the production of vascular endothelial growth factor-beta (VEGF-β) in astrocytes, collectively attenuating CNS inflammation (61) (Figure 1B).
2.2.3 Potential exacerbating effects on the impaired BBB
BBB is a critical interface between the circulatory system and the CNS. The gut microbiota can influence BBB permeability by regulating the expression of tight junction proteins (62, 63). In addition, the microbiota can modulate the development and maintenance of the BBB through epigenetic mechanisms mediated by metabolites such as SCFAs (41)(Figure 1C).
Disruption of the BBB by ionizing radiation is a dynamic process that is potentially associated with the release of various substances following radiation exposure (64–66). Radiation-induced endothelial cell damage alters vascular permeability, thereby compromising BBB integrity and triggering inflammatory responses (57, 65). Early BBB disruption induced by radiation is closely associated with TNF-α activation and the downregulation of the tight junction protein claudin-5 (67). High-mobility group box 1 (HMGB1) is activated and passively released by macrophages and monocytes into the extracellular environment, further increasing endothelial permeability (68, 69)(Figure 1C).
Based on the evidence that radiation directly compromises BBB integrity (57, 63, 65–67, 70), a plausible mechanistic hypothesis is proposed. Gut dysbiosis frequently associated with RBI may elevate systemic levels of gut-derived neuroactive metabolites and microbial products (e.g., lipopolysaccharide). Concurrently, radiation-induced BBB damage and increased permeability may facilitate the enhanced entry of these circulating factors into the CNS. The translocation of such substances may contribute to a toxic inflammatory milieu within the brain, disrupting immune homeostasis, thereby exacerbating a vicious cycle of neuroinflammation (70).
2.2.4 Remote regulation of central inflammation by the gut microbiota
The gut microbiota can also exert finely tuned negative regulation of central inflammation through the modulation of specific immune cell populations. For instance, the gut microbiota can regulate the maturation of natural killer (NK) cells in the meninges, promoting their production of anti-inflammatory interferon-gamma (IFN-γ) (71). These “gut-licensed” IFN-γ+ NK cells subsequently migrate into the brain parenchyma and induce the transformation of astrocytes into a specialized anti-inflammatory phenotype (LAMP1+TRAIL+) (71). This astrocyte subtype can markedly suppress inflammatory responses within the CNS, revealing a unique ascending pathway through which the gut microbiota influences central immune regulation(Figure 1D).
In summary, a bidirectional and self-amplifying pathological loop is established between RBI and the gut microbiota via the MGBA. In the descending pathway, RBI disrupts intestinal barrier integrity and immune homeostasis through brain-derived inflammatory and stress-related signals, leading to microbial dysbiosis. In the ascending pathway, the dysbiotic gut microbiota feeds back to exacerbate central neuroinflammation, neuronal injury, and cognitive dysfunction through mechanisms including aberrant microglial activation, altered neuroactive metabolite profiles, aggravated BBB damage, and remote immune regulation. This cyclical amplification mechanism underscores the central role of the MGBA in the pathogenesis of RBI and highlights potential therapeutic strategies and intervention targets for the prevention and treatment of RBI through modulation of the gut microbiota (e.g., probiotics, prebiotics, or specific metabolites).
3 Signal transduction disruption
Bidirectional communication between the gut and the brain depends not only on immune and inflammatory mediators but also on complex neural and molecular signaling pathways. The vagus nerve represents the most direct neural connection between the gut and the brain, and its afferent and efferent fibers play a central role in signal transmission within the MGBA (72). Increasing evidence indicates that the gut microbiota and its metabolites can actively influence brain structure, function, and plasticity through these neural pathways, as well as by modulating key host metabolic pathways (e.g., tryptophan metabolism), in a bottom-up manner (58). Disruption of these signaling mechanisms is critically involved in RBI(Figure 2).
Figure 2. Role of the gut–brain axis in signaling pathways in radiation brain injury. (1) Vagus nerve: Afferent fibers sense microbial metabolites (e.g., SCFAs) and transmit signals to the brain; efferent fibers inhibit intestinal inflammation via cholinergic anti-inflammatory pathway, regulating gut microbiota. (2) Tryptophan metabolism: Kynurenine pathway produces neuroprotective kynurenic acid (astrocytes) and neurotoxic quinolinic acid (microglia), balanced by gut microbiota. (3) Intervention potential: Prebiotics/drugs (e.g., total glucosides of paeony) modulate gut microbiota, activate cerebral cAMP/CREB/BDNF pathway, protecting neurons and improving cognition. Created in BioRender. Jiejie, W. (2026) https://BioRender.com/necagsv.
3.1 Bidirectional regulatory role of the vagus nerve
The vagus nerve is the most direct neural pathway connecting the gut and the brain. Composed of afferent (sensory) and efferent (motor) fibers, it forms a complete perception–regulation circuit and serves as a core component of gut–brain axis signaling (41).
Vagal afferent fibers are responsible for sensing signals from the gut and transmitting them to the brain. These fibers can detect changes in microbial metabolites (e.g., SCFAs) and selectively activate vagal afferent neurons through receptor-mediated mechanisms (72). The transmitted signals are relayed via vagal afferent nuclei and ultimately influence higher-order brain functions. Experimental studies have demonstrated that electrical stimulation of vagal afferent fibers can directly modulate neurotransmitter levels in the brain, providing empirical support for the modulation of CNS states through this pathway (73).
Vagal efferent fibers mediate top-down regulation of the gut by the brain. Acetylcholine released from efferent terminals suppresses the release of pro-inflammatory cytokines, such as TNF-α, from M1-type macrophages in the intestinal lamina propria by activating the cholinergic anti-inflammatory pathway, thereby reducing local inflammatory responses (74, 75). This regulation of the intestinal immune environment can, in turn, influence the composition and function of the gut microbiota (76). Collectively, these mechanisms establish the vagus nerve as the functional basis for bidirectional gut–brain communication in RBI.
3.2 Central role of the tryptophan metabolic pathway
Beyond neural pathways, the gut microbiota also directly or indirectly influences signal homeostasis in the CNS by modulating key host metabolites. Among these, the metabolic pathway of the essential amino acid tryptophan is of particular importance. Tryptophan can cross the BBB, and its metabolism proceeds along two major branches that jointly regulate neuroactivity and immune balance. Certain gut microbes can metabolize tryptophan, thereby reducing its availability to the host (77).
Tryptophan serves as a precursor for the important neurotransmitter serotonin (5-hydroxytryptamine, 5-HT). In the brain, tryptophan is converted into 5-HT through hydroxylation and decarboxylation reactions. Serotonin is broadly involved in the regulation of mood, cognition, and neural repair (78). In parallel, the kynurenine pathway of tryptophan metabolism plays a central role in balancing neuroprotection and neurotoxicity. The intermediate metabolite kynurenine is taken up by different glial cell types in the brain, leading to divergent metabolic fates: astrocytes convert it into the neuroprotective metabolite kynurenic acid, whereas microglia may metabolize it into the neurotoxic compound quinolinic acid (78). Therefore, multilevel regulation of tryptophan metabolism by the gut microbiota represents a critical determinant of neuroimmune homeostasis in RBI.
3.3 Intervention and repair potential of signaling pathways
Positive modulation of the gut microbiota can activate protective signaling pathways within the CNS. Studies have shown that in irradiated mouse models, supplementation with total glucosides of paeony effectively modulates the gut microbiota, subsequently activating the cerebral cyclic adenosine monophosphate (cAMP)/cAMP response element-binding protein (CREB)/brain-derived neurotrophic factor (BDNF) signaling pathway. Activation of this pathway is associated with protection of hippocampal neurons and improvement in cognitive and spatial memory functions (79, 80). These findings demonstrate that interventions using prebiotics or microbiota-targeting drugs can activate beneficial neuroprotective and neuroplastic signaling pathways in a bottom-up manner.
Conversely, disruption of microbiota homeostasis leads to a series of adverse consequences. Evidence indicates that antibiotic-induced gut microbiota dysbiosis reduces the expression of genes associated with homeostatic microglial function (e.g., purinergic receptor genes P2ry12 and P2ry13) in the mouse spinal cord, while upregulating genes linked to neurodegenerative pathology (e.g., apolipoprotein E gene Apoe) (81). These findings suggest that an intact gut microbiota is essential for maintaining microglia in a homeostatic phenotype and supporting their normal physiological functions.
4 DNA damage repair dysfunction
Radiation exposure directly induces DNA double-strand breaks, leading to genomic instability and oxidative stress, and ultimately resulting in cell death (82). This DNA damage rapidly activates damage sensors such as ataxia-telangiectasia mutated (ATM) and ATM and Rad3-related (ATR), as well as downstream transcription factors including NF-κB, CREB, and activator protein-1 (AP-1). Activation of these pathways subsequently drives the expression of pro-inflammatory cytokines, such as interleukin-1β (IL-1β) and TNF-α. These systemic inflammatory responses may further disrupt intestinal barrier homeostasis and alter gut microbiota composition (4, 83).
Urolithin A (UroA), a gut microbiota–derived metabolite of ellagic acid, is associated not only with the restoration of intestinal microbial balance following radiation exposure but also with cellular protection through inhibition of p53-mediated apoptosis. UroA exerts protective effects on cellular DNA by suppressing NF-κB signaling, maintaining intracellular calcium homeostasis, and alleviating oxidative stress (84, 85).
5 Disruption of oxidative stress homeostasis
Ionizing radiation induces excessive production of reactive oxygen species (ROS) in the brain, resulting in neuronal and glial cell injury, mitochondrial dysfunction, and secondary DNA damage (86). Nuclear factor erythroid 2–related factor 2 (Nrf-2), a key endogenous transcriptional regulator of antioxidant responses, suppresses excessive ROS accumulation. Deficiency of Nrf-2 exacerbates radiation-induced injury and is accompanied by immune cell infiltration and elevated levels of pro-inflammatory cytokines (such as IL-6, IFN-γ, TNF-α), thereby disrupting gut microbiota homeostasis (87).
In parallel, the gut microbiota and its metabolites play an integral role in regulating oxidative stress within the brain. Experimental studies have demonstrated that exposure to 0.5 Gy radiation increases ROS levels in microglia, whereas exposure to 2 Gy induces hippocampal microglial activation and alters the activity of mitochondrial electron transport chain enzymes. These processes are regulated by the gut microbiota (55).
Protective microbial metabolites, including butyrate, as well as prostaglandin F2α and phenylacetylglutamine, can mitigate radiation-induced toxicity by reducing oxidative stress and enhancing mitochondrial function (88). In contrast, certain microbial metabolites, such as N6-carboxymethyllysine, may promote oxidative stress in microglia and impair mitochondrial function (89). Collectively, these findings indicate that gut microbiota–derived metabolites play a complex and pivotal role in RBI progression by modulating microglial redox balance and mitochondrial homeostasis.
6 Conclusions
Radiation therapy remains a cornerstone in the treatment of head and neck tumors; however, RBI in normal tissues continues to represent a significant unmet clinical challenge despite advances in treatment precision (90, 91). This review elucidates the role of the gut microbiota in brain injury, with a particular focus on bidirectional interactions mediated by the MGBA. We discuss how the gut microbiota modulates brain injury and repair through this axis and, conversely, how RBI reshapes gut microbial homeostasis. The underlying mechanisms primarily involve immune and inflammatory responses, signal transduction, DNA damage, and oxidative stress, all of which contribute to MGBA-mediated crosstalk. In addition, the potential application of deep learning models to elucidate the complex bidirectional regulatory roles of the MGBA in RBI is introduced.
Nevertheless, given the complexity of the biological mechanisms underlying RBI, a unified understanding of bidirectional MGBA communication—specifically, how injured brain tissue influences the gut microbiota and how the gut microbiota participates in brain repair—remains limited. Current studies on the interaction between RBI and the gut microbiota are relatively scarce and largely provide indirect evidence, underscoring the need for further investigation to elucidate precise mechanisms. As normal intestinal colonizers, gut microbiota are essential for host physiological homeostasis. RBI is frequently accompanied by gut microbiota dysbiosis, characterized by alterations in both bacterial abundance and diversity. Because distinct bacterial strains exert specific physiological functions, future studies should refine strain-level analyses and adopt interdisciplinary approaches integrating microbiology and immunology to support precision interventions for RBI. Furthermore, due to the presence of the BBB, communication between gut microbiota and brain tissue is typically indirect and primarily mediated by microbial metabolites or the vagus nerve. However, RBI is associated with BBB disruption, potentially enabling more direct microbial interactions with brain tissue. Current understanding of such interactions remains limited, highlighting the need for further systematic investigation. Alterations in the gut microbiota have the potential to feed back and modify brain function, as well as to influence recovery following injury. Such changes in the gut microbiota may serve as valuable biomarkers for monitoring disease progression, improving the prognosis of RBI, and even as therapeutic targets for addressing secondary injuries in patients with RBI. A comprehensive understanding of the complex direct and indirect interactions between the gut microbiota and RBI is therefore essential for the development of effective and targeted interventions to mitigate the deleterious effects of this condition.
Although the mechanisms underlying the gut microbiota–brain axis are complex and remain incompletely elucidated, the role of the gut microbiota and its metabolites should not be underestimated. The gut microbiota–derived metabolite indole-3-propionate (IPA) has been shown to promote sensory nerve axonal regeneration and functional recovery by recruiting neutrophils to the dorsal root ganglion. These findings indicate that microbial metabolites represent promising therapeutic candidates for nerve repair, axonal regeneration, and the enhancement of neurological recovery (92). However, whether the gut microbiota and its metabolites can serve as effective therapeutic targets for patients with RBI requires validation through well-controlled clinical trials in humans. In addition, the safety profiles of microbiota- and metabolite-based therapies warrant further systematic evaluation.
With ongoing advances in omics technologies and deep learning models, the translation of fundamental knowledge regarding the MGBA into therapeutic strategies for RBI is expected to become increasingly effective. The potential mechanisms discussed in this review, including radiation-induced effects on microglia, DNA damage, and ROS, may directly or indirectly influence the expression of inflammatory mediators, thereby affecting microbial homeostasis. Conversely, microbes and their metabolites can indirectly regulate immune factors, further modulating the progression of RBI. Given the complexity of these interactions, deep learning approaches are well suited to integrate multi-omics and multidimensional data, enabling interpretation from a more comprehensive and systematic perspective. Moreover, the rapid development of large language models, such as ChatGPT4, highlights the potential to integrate existing foundational knowledge of the MGBA to construct generalized brain–gut axis models, thereby facilitating the identification of potential interactions between gut microbes and brain tissue in RBI and revealing novel therapeutic avenues.
Collectively, a comprehensive understanding of the interplay between the gut microbiota and brain tissue in RBI may provide novel insights into radiation therapy, offer more effective strategies for future clinical practice, and ultimately improve the quality of life of patients affected by brain injury.
Author contributions
YY: Writing – original draft, Writing – review & editing. NW: Investigation, Writing – original draft. KN: Funding acquisition, Writing – review & editing. XD: Funding acquisition, Resources, Writing – review & editing.
Funding
The author(s) declared that financial support was received for this work and/or its publication. This work was funded by the Youth Research Foundation of Shanxi Province(No. 20210302124283), China, the National Key R&D Program of China (2023YFA1800900 and 2018YFC0910502) and the National Science Foundation of China (Grant Nos. 32071465).
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Al-Rubaiey S, Senger C, Bukatz J, Krantchev K, Janas A, Eitner C, et al. Determinants of cerebral radionecrosis in animal models: A systematic review. Radiother Oncol. (2024) 199:110444. doi: 10.1016/j.radonc.2024.110444
2. Strohm AO, Johnston C, Hernady E, Marples B, O'Banion MK, and Majewska AK. Cranial irradiation disrupts homeostatic microglial dynamic behavior. J Neuroinflammation. (2024) 21:82. doi: 10.1186/s12974-024-03073-z
3. Xu L, Huang H, Liu T, Yang T, and Yi X. Exposure to X-rays causes depression-like behaviors in mice via HMGB1-mediated pyroptosis. Neuroscience. (2022) 481:99–110. doi: 10.1016/j.neuroscience.2021.11.023
4. Gan C, Li W, Xu J, Pang L, Tang L, Yu S, et al. Advances in the study of the molecular biological mechanisms of radiation-induced brain injury. Am J Cancer Res. (2023) 13:3275–99.
5. Liu Q, Huang Y, Duan M, Yang Q, Ren B, and Tang F. Microglia as therapeutic target for radiation-induced brain injury. Int J Mol Sci. (2022) 23:8286. doi: 10.3390/ijms23158286
6. Turnquist C, Harris BT, and Harris CC. Radiation-induced brain injury: current concepts and therapeutic strategies targeting neuroinflammation. Neurooncol Adv. (2020) 2:vdaa057. doi: 10.1093/noajnl/vdaa057
7. Wang Y, Tian J, Liu D, Li T, Mao Y, and Zhu C. Microglia in radiation-induced brain injury: Cellular and molecular mechanisms and therapeutic potential. CNS Neurosci Ther. (2024) 30:e14794. doi: 10.1111/cns.14794
8. Makale MT, McDonald CR, Hattangadi-Gluth JA, and Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol. (2017) 13:52–64. doi: 10.1038/nrneurol.2016.185
9. Wang Y, Bao X, Zhang Y, and Wu Q. The current research status of the mechanisms and treatment of radioactive brain injury. Am J Cancer Res. (2024) 14:5598–613. doi: 10.62347/BEAU4974
10. Li L, Liu X, Han C, Tian L, Wang Y, and Han B. Ferroptosis in radiation-induced brain injury: roles and clinical implications. BioMed Eng Online. (2024) 23:93. doi: 10.1186/s12938-024-01288-y
11. Sender R, Fuchs S, and Milo R. Revised estimates for the number of human and bacteria cells in the body. PloS Biol. (2016) 14:e1002533. doi: 10.1371/journal.pbio.1002533
12. Foster JA, Rinaman L, and Cryan JF. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiol Stress. (2017) 7:124–36. doi: 10.1016/j.ynstr.2017.03.001
13. Treangen TJ, Wagner J, Burns MP, and Villapol S. Traumatic brain injury in mice induces acute bacterial dysbiosis within the fecal microbiome. Front Immunol. (2018) 9:2757. doi: 10.3389/fimmu.2018.02757
14. Fung TC, Olson CA, and Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. (2017) 20:145–55. doi: 10.1038/nn.4476
15. Simmons DA, Lartey FM, Schüler E, Rafat M, King G, Kim A, et al. Reduced cognitive deficits after FLASH irradiation of whole mouse brain are associated with less hippocampal dendritic spine loss and neuroinflammation. Radiother Oncol. (2019) 139:4–10. doi: 10.1016/j.radonc.2019.06.006
16. Alaghband Y, Cheeks SN, Allen BD, Montay-Gruel P, Doan NL, Petit B, et al. Neuroprotection of radiosensitive juvenile mice by ultra-high dose rate FLASH irradiation. Cancers (Basel). (2020) 12:1671. doi: 10.3390/cancers12061671
17. Mayer EA, Tillisch K, and Gupta A. Gut/brain axis and the microbiota. J Clin Invest. (2015) 125:926–38. doi: 10.1172/JCI76304
18. Agustí A, García-Pardo MP, López-Almela I, Campillo I, Maes M, Romaní-Pérez M, et al. Interplay between the gut-brain axis, obesity and cognitive function. Front Neurosci. (2018) 12:155. doi: 10.3389/fnins.2018.00155
19. Al-Qadami G, Van Sebille Y, Le H, and Bowen J. Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis. Expert Rev Gastroenterol Hepatol. (2019) 13:485–96. doi: 10.1080/17474124.2019.1595586
20. Ohara TE and Hsiao EY. Microbiota-neuroepithelial signalling across the gut-brain axis. Nat Rev Microbiol. (2025) 23:371–84. doi: 10.1038/s41579-024-01136-9
21. Cui M, Xiao H, Li Y, Zhou L, Zhao S, Luo D, et al. Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med. (2017) 9:448–61. doi: 10.15252/emmm.201606932
22. Round JL and Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. (2009) 9:313–23. doi: 10.1038/nri2515
23. Cerf-Bensussan N and Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol. (2010) 10:735–44. doi: 10.1038/nri2850
24. Rogier EW, Frantz AL, Bruno ME, and Kaetzel CS. Secretory igA is concentrated in the outer layer of colonic mucus along with gut bacteria. Pathogens. (2014) 3:390–403. doi: 10.3390/pathogens3020390
25. Ashonibare VJ, Akorede BA, Ashonibare PJ, Akhigbe TM, and Akhigbe RE. Gut microbiota-gonadal axis: the impact of gut microbiota on reproductive functions. Front Immunol. (2024) 15:1346035. doi: 10.3389/fimmu.2024.1346035
26. Dowling LR, Strazzari MR, Keely S, and Kaiko GE. Enteric nervous system and intestinal epithelial regulation of the gut-brain axis. J Allergy Clin Immunol. (2022) 150:513–22. doi: 10.1016/j.jaci.2022.07.015
27. Barrio C, Arias-Sánchez S, and Martín-Monzón I. The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review. Psychoneuroendocrinology. (2022) 137:105640. doi: 10.1016/j.psyneuen.2021.105640
28. Hu J, Jiao W, Tang Z, Wang C, Li Q, Wei M, et al. Quercetin inclusion complex gels ameliorate radiation-induced brain injury by regulating gut microbiota. BioMed Pharmacother. (2023) 158:114142. doi: 10.1016/j.biopha.2022.114142
29. Mazarati A, Medel-Matus JS, Shin D, Jacobs JP, and Sankar R. Disruption of intestinal barrier and endotoxemia after traumatic brain injury: Implications for post-traumatic epilepsy. Epilepsia. (2021) 62:1472–81. doi: 10.1111/epi.16909
30. Fried S, Wemelle E, Cani PD, and Knauf C. Interactions between the microbiota and enteric nervous system during gut-brain disorders. Neuropharmacology. (2021) 197:108721. doi: 10.1016/j.neuropharm.2021.108721
31. Zhang Y, Hu J, Song X, Dai J, Tang Z, Huang G, et al. The effects of Lactobacillus reuteri microcapsules on radiation-induced brain injury by regulating the gut microenvironment. Food Funct. (2023) 14:10041–51. doi: 10.1039/D3FO03008C
32. Luo N, Zhu W, Li X, Fu M, Peng X, Yang F, et al. Impact of gut microbiota on radiation-associated cognitive dysfunction and neuroinflammation in mice. Radiat Res. (2022) 197:350–64. doi: 10.1667/RADE-21-00006.1
33. Macpherson AJ, Pachnis V, and Prinz M. Boundaries and integration between microbiota, the nervous system, and immunity. Immunity. (2023) 56:1712–26. doi: 10.1016/j.immuni.2023.07.011
34. Yang Y, Gharaibeh RZ, Newsome RC, and Jobin C. Amending microbiota by targeting intestinal inflammation with TNF blockade attenuates development of colorectal cancer. Nat Cancer. (2020) 1:723–34. doi: 10.1038/s43018-020-0078-7
35. Borre YE, O'Keeffe GW, Clarke G, Stanton C, Dinan TG, and Cryan JF. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med. (2014) 20:509–18. doi: 10.1016/j.molmed.2014.05.002
36. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. (2012) 338:120–3. doi: 10.1126/science.1224820
37. Weiss GA and Hennet T. Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci. (2017) 74:2959–77. doi: 10.1007/s00018-017-2509-x
38. Ihara S, Hirata Y, Serizawa T, Suzuki N, Sakitani K, Kinoshita H, et al. TGF-β Signaling in dendritic cells governs colonic homeostasis by controlling epithelial differentiation and the luminal microbiota. J Immunol. (2016) 196:4603–13. doi: 10.4049/jimmunol.1502548
39. Sudo N. Biogenic amines: signals between commensal microbiota and gut physiology. Front Endocrinol (Lausanne). (2019) 10:504. doi: 10.3389/fendo.2019.00504
40. Feng X, Frias ES, Paladini MS, Chen D, Boosalis Z, Becker M, et al. Functional role of brain-engrafted macrophages against brain injuries. J Neuroinflammation. (2021) 18:232. doi: 10.1186/s12974-021-02290-0
41. Osadchiy V, Martin CR, and Mayer EA. The gut-brain axis and the microbiome: mechanisms and clinical implications. Clin Gastroenterol Hepatol. (2019) 17:322–32. doi: 10.1016/j.cgh.2018.10.002
42. Ma EL, Smith AD, Desai N, Cheung L, Hanscom M, Stoica BA, et al. Bidirectional brain-gut interactions and chronic pathological changes after traumatic brain injury in mice. Brain Behav Immun. (2017) 66:56–69. doi: 10.1016/j.bbi.2017.06.018
43. Patterson TT, Nicholson S, Wallace D, Hawryluk GWJ, and Grandhi R. Complex feed-forward and feedback mechanisms underlie the relationship between traumatic brain injury and the gut-microbiota-brain axis. Shock. (2019) 52:318–25. doi: 10.1097/SHK.0000000000001278
44. Rothhammer V, Borucki DM, Tjon EC, Takenaka MC, Chao CC, Ardura-Fabregat A, et al. Microglial control of astrocytes in response to microbial metabolites. Nature. (2018) 557:724–8. doi: 10.1038/s41586-018-0119-x
45. Sharon G, Sampson TR, Geschwind DH, and Mazmanian SK. The central nervous system and the gut microbiome. Cell. (2016) 167:915–32. doi: 10.1016/j.cell.2016.10.027
46. Nayak D, Roth TL, and McGavern DB. Microglia development and function. Annu Rev Immunol. (2014) 32:367–402. doi: 10.1146/annurev-immunol-032713-120240
47. Lumniczky K, Szatmári T, and Sáfrány G. Ionizing radiation-induced immune and inflammatory reactions in the brain. Front Immunol. (2017) 8:517. doi: 10.3389/fimmu.2017.00517
48. Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. (2015) 18:965–77. doi: 10.1038/nn.4030
49. Korimerla N and Wahl DR. A complementary strategy to mitigate radiation-induced cognitive decline. Cancer Res. (2021) 81:1635–6. doi: 10.1158/0008-5472.CAN-20-4277
50. Wang J, Pan H, Lin Z, Xiong C, Wei C, Li H, et al. Neuroprotective effect of fractalkine on radiation-induced brain injury through promoting the M2 polarization of microglia. Mol Neurobiol. (2021) 58:1074–87. doi: 10.1007/s12035-020-02138-3
51. Wang M, Pan W, Xu Y, Zhang J, Wan J, and Jiang H. Microglia-mediated neuroinflammation: A potential target for the treatment of cardiovascular diseases. J Inflammation Res. (2022) 15:3083–94. doi: 10.2147/JIR.S350109
52. Greene-Schloesser D, Payne V, Peiffer AM, Hsu FC, Riddle DR, Zhao W, et al. The peroxisomal proliferator-activated receptor (PPAR) α agonist, fenofibrate, prevents fractionated whole-brain irradiation-induced cognitive impairment. Radiat Res. (2014) 181:33–44. doi: 10.1667/RR13202.1
53. Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, and Burnet PWJ. Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci. (2016) 39:763–81. doi: 10.1016/j.tins.2016.09.002
54. Matcovitch-Natan O, Winter DR, Giladi A, Vargas Aguilar S, Spinrad A, Sarrazin S, et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science. (2016) 353:aad8670. doi: 10.1126/science.aad8670
55. Zheng H, Zhang C, Zhang J, and Duan L. Sentinel or accomplice": gut microbiota and microglia crosstalk in disorders of gut-brain interaction. Protein Cell. (2023) 14:726–42. doi: 10.1093/procel/pwad020
56. Song L, Sun Q, Zheng H, Zhang Y, Wang Y, Liu S, et al. Roseburia hominis Alleviates Neuroinflammation via Short-Chain Fatty Acids through Histone Deacetylase Inhibition. Mol Nutr Food Res. (2022) 66:e2200164. doi: 10.1002/mnfr.202200164
57. Magnusson MK, Isaksson S, and Öhman L. The anti-inflammatory immune regulation induced by butyrate is impaired in inflamed intestinal mucosa from patients with ulcerative colitis. Inflammation. (2020) 43:507–17. doi: 10.1007/s10753-019-01133-8
58. Mayer EA, Nance K, and Chen S. The gut-brain axis. Annu Rev Med. (2022) 73:439–53. doi: 10.1146/annurev-med-042320-014032
59. McMillin M, Frampton G, Grant S, Khan S, Diocares J, Petrescu A, et al. Bile acid-mediated sphingosine-1-phosphate receptor 2 signaling promotes neuroinflammation during hepatic encephalopathy in mice. Front Cell Neurosci. (2017) 11:191. doi: 10.3389/fncel.2017.00191
60. Fiorucci S, Marchianò S, Distrutti E, and Biagioli M. Bile acids and their receptors in hepatic immunity. Liver Res. (2025) 9:1–16. doi: 10.1016/j.livres.2025.01.005
61. Lee B, Lee SM, Song JW, and Choi JW. Gut microbiota metabolite messengers in brain function and pathology at a view of cell type-based receptor and enzyme reaction. Biomol Ther (Seoul). (2024) 32:403–23. doi: 10.4062/biomolther.2024.009
62. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. (2014) 6:263ra158. doi: 10.1126/scitranslmed.3009759
63. Nakkazi A, Forster D, Whitfield GA, Dyer DP, and Dickie BR. A systematic review of normal tissue neurovascular unit damage following brain irradiation-Factors affecting damage severity and timing of effects. Neurooncol Adv. (2024) 6:vdae098. doi: 10.1093/noajnl/vdae098
64. Jaillet C, Morelle W, Slomianny MC, Paget V, Tarlet G, Buard V, et al. Radiation-induced changes in the glycome of endothelial cells with functional consequences. Sci Rep. (2017) 7:5290. doi: 10.1038/s41598-017-05563-y
65. Templin T, Sharma P, Guida P, and Grabham P. Short-term effects of low-LET radiation on the endothelial barrier: uncoupling of PECAM-1 and the production of endothelial microparticles. Radiat Res. (2016) 186:602–13. doi: 10.1667/RR14510.1
66. Salian VS, Curan GL, Lowe VJ, Tang X, Kalari KR, and Kandimalla KK. Elucidating molecular mechanisms governing TNF-alpha-mediated regulation of amyloid beta 42 uptake in blood-brain barrier endothelial cells. Mol Pharmacol. (2025) 108:100088. doi: 10.1101/2025.01.28.635286
67. Yoshida Y, Sejimo Y, Kurachi M, Ishizaki Y, Nakano T, and Takahashi A. X-ray irradiation induces disruption of the blood-brain barrier with localized changes in claudin-5 and activation of microglia in the mouse brain. Neurochem Int. (2018) 119:199–206. doi: 10.1016/j.neuint.2018.03.002
68. Kang L, Guo N, Liu X, Wang X, Guo W, Xie SM, et al. High mobility group box-1 protects against Aflatoxin G(1)-induced pulmonary epithelial cell damage in the lung inflammatory environment. Toxicol Lett. (2020) 331:92–101. doi: 10.1016/j.toxlet.2020.05.013
69. Shang D, Peng T, Gou S, Li Y, Wu H, Wang C, et al. High mobility group box protein 1 boosts endothelial albumin transcytosis through the RAGE/src/caveolin-1 pathway. Sci Rep. (2016) 6:32180. doi: 10.1038/srep32180
70. Schumacher S, Tahiri H, Ezan P, Rouach N, Witschas K, and Leybaert L. Inhibiting astrocyte connexin-43 hemichannels blocks radiation-induced vesicular VEGF-A release and blood-brain barrier dysfunction. Glia. (2024) 72:34–50. doi: 10.1002/glia.24460
71. Sanmarco LM, Wheeler MA, Gutiérrez-Vázquez C, Polonio CM, Linnerbauer M, Pinho-Ribeiro FA, et al. Gut-licensed IFNγ(+) NK cells drive LAMP1(+)TRAIL(+) anti-inflammatory astrocytes. Nature. (2021) 590:473–9. doi: 10.1038/s41586-020-03116-4
72. Jameson KG, Kazmi SA, Ohara TE, Son C, Yu KB, Mazdeyasnan D, et al. Select microbial metabolites in the small intestinal lumen regulate vagal activity via receptor-mediated signaling. iScience. (2025) 28:111699. doi: 10.1016/j.isci.2024.111699
73. Olsen LK, Solis E Jr., McIntire LK, and Hatcher-Solis CN. Vagus nerve stimulation: mechanisms and factors involved in memory enhancement. Front Hum Neurosci. (2023) 17:1152064. doi: 10.3389/fnhum.2023.1152064
74. Yuan PQ and Taché Y. Abdominal surgery induced gastric ileus and activation of M1-like macrophages in the gastric myenteric plexus: prevention by central vagal activation in rats. Am J Physiol Gastrointest Liver Physiol. (2017) 313:G320–g9. doi: 10.1152/ajpgi.00121.2017
75. Liu J, Zheng K, Dong L, Lin J, Zhang C, Xie Y, et al. Clinical applications and mechanisms of vagus nerve stimulation in the treatment of immune diseases: a review. Int J Surg. (2025) 111:9496–506. doi: 10.1097/JS9.0000000000003160
76. Bonaz B, Bazin T, and Pellissier S. The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci. (2018) 12:49. doi: 10.3389/fnins.2018.00049
77. Agus A, Planchais J, and Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. (2018) 23:716–24. doi: 10.1016/j.chom.2018.05.003
78. Platten M, Nollen EAA, Röhrig UF, Fallarino F, and Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. (2019) 18:379–401. doi: 10.1038/s41573-019-0016-5
79. Wang W, Cui B, Nie Y, Sun L, and Zhang F. Radiation injury and gut microbiota-based treatment. Protein Cell. (2024) 15:83–97. doi: 10.1093/procel/pwad044
80. Song C, Duan F, Ju T, Qin Y, Zeng D, Shan S, et al. Eleutheroside E supplementation prevents radiation-induced cognitive impairment and activates PKA signaling via gut microbiota. Commun Biol. (2022) 5:680. doi: 10.1038/s42003-022-03602-7
81. Cox LM, Calcagno N, Gauthier C, Madore C, Butovsky O, and Weiner HL. The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis. Microbiome. (2022) 10:47. doi: 10.1186/s40168-022-01232-z
82. Kim SB, Heo JI, Kim H, and Kim KS. Acetylation of PGC1α by histone deacetylase 1 downregulation is implicated in radiation-induced senescence of brain endothelial cells. J Gerontol A Biol Sci Med Sci. (2019) 74:787–93. doi: 10.1093/gerona/gly167
83. Jonak K, Kurpas M, Szoltysek K, Janus P, Abramowicz A, and Puszynski K. A novel mathematical model of ATM/p53/NF- κB pathways points to the importance of the DDR switch-off mechanisms. BMC Syst Biol. (2016) 10:75. doi: 10.1186/s12918-016-0293-0
84. Zhang Y, Dong Y, Lu P, Wang X, Li W, Dong H, et al. Gut metabolite Urolithin A mitigates ionizing radiation-induced intestinal damage. J Cell Mol Med. (2021) 25:10306–12. doi: 10.1111/jcmm.16951
85. Abdelazeem KNM, Kalo MZ, Beer-Hammer S, and Lang F. The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs. Sci Rep. (2021) 11:7117. doi: 10.1038/s41598-021-86514-6
86. Kumar R, Kumari P, and Kumar R. Central nervous system response against ionizing radiation exposure: cellular, biochemical, and molecular perspectives. Mol Neurobiol. (2025) 62:7268–95. doi: 10.1007/s12035-025-04712-z
87. Tian X, Wang F, Luo Y, Ma S, Zhang N, Sun Y, et al. Protective role of nuclear factor-erythroid 2-related factor 2 against radiation-induced lung injury and inflammation. Front Oncol. (2018) 8:542. doi: 10.3389/fonc.2018.00542
88. Yi Y, Lu W, Shen L, Wu Y, and Zhang Z. The gut microbiota as a booster for radiotherapy: novel insights into radio-protection and radiation injury. Exp Hematol Oncol. (2023) 12:48. doi: 10.1186/s40164-023-00410-5
89. Mossad O, Batut B, Yilmaz B, Dokalis N, Mezö C, Nent E, et al. Gut microbiota drives age-related oxidative stress and mitochondrial damage in microglia via the metabolite N(6)-carboxymethyllysine. Nat Neurosci. (2022) 25:295–305. doi: 10.1038/s41593-022-01027-3
90. Montay-Gruel P, Markarian M, Allen BD, Baddour JD, Giedzinski E, Jorge PG, et al. Ultra-high-dose-rate FLASH irradiation limits reactive gliosis in the brain. Radiat Res. (2020) 194:636–45. doi: 10.1667/RADE-20-00067.1
91. Eling L, Bouchet A, Nemoz C, Djonov V, Balosso J, Laissue J, et al. Ultra high dose rate Synchrotron Microbeam Radiation Therapy. Preclinical evidence in view of a clinical transfer. Radiother Oncol. (2019) 139:56–61. doi: 10.1016/j.radonc.2019.06.030
Keywords: brain tumors, gut microbiota, microbiota–gut–brain axis, radiation therapy, radiation-induced brain injury
Citation: Yuan Y, Wang N, Ning K and Dang X (2026) Bidirectional interactions along the microbiota–gut–brain axis in radiation-induced brain injury: mechanisms and therapeutic insights. Front. Oncol. 16:1774021. doi: 10.3389/fonc.2026.1774021
Received: 23 December 2025; Accepted: 20 January 2026; Revised: 16 January 2026;
Published: 05 February 2026.
Edited by:
Timothy James Kinsella, Brown University, United StatesReviewed by:
Fei Liang, The First People’s Hospital of Lianyungang City, ChinaYuxi Yi, Shanghai Jiao Tong University, China
Copyright © 2026 Yuan, Wang, Ning and Dang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kang Ning, bmluZ2thbmdAaHVzdC5lZHUuY24=; Xuhong Dang, ZGFuZ3h1aG9uZzAwNUAxNjMuY29t